Formulation and Optimization of Lamotrigin Fast Dissolving Tablet

Similar documents
Formulation and In-vitro Evaluation of Chewable Tablets of Montelukast Sodium

Formulation and Evaluation

Formulation and evaluation of immediate release salbutamol sulphate

Formulation and Evaluation of Amlodipine besylate orally disintegrating tablet

Formulation and evaluation of Orodispersible tablets to enhance dissolution rate of Lamotrigine by using Solid Dispersion Technique

Karnataka Department of Pharmaceutical Technology, H.K.E. Society s College of Pharmacy, Gulbarga, Karnataka ABSTRACT KEYWORDS:

Formulation and Development of Sustained Release Tablets of Valsartan Sodium

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

Design and development of fast Melting Tablets of Terbutaline Sulphate

EFFECT OF SUPERDISINTEGRANTS ON RELEASE OF DOMPERIDONE FROM FAST DISSOLVING TABLETS

Available Online through

The purpose of the present investigation was to design a formulation of orodispersible tablets of Etoricoxib by adopting

INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND CHEMICAL SCIENCES

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

Formulation and evaluation of fast dissolving tablet of aceclofenac

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

FAST DISPERSING TABLETS REVIEW Chetan V. Suryawanshi*, N. A. Gujrathi, B. R. Rane

Formulation and evaluation of sublingual tablets of lisinopril

FORMULATION DEVELOPMENT AND IN-VITRO EVALUATION OF ORALLY DISINTEGRATING TABLETS OF AMLODIPINE BESYLATE

FORMULATION DEVELOPMENT AND EVALUATION OF MOUTH DISSOLVING TABLET OF TRAMADOL HYDROCHLORIDE

Received on: Accepted on:

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

B. Jayakar et. al. FORMULATION AND EVALUATION OF ORODISPERSIBLE TABLET OF CELECOXIB R. Margret Chandira, Shyam Sharma, Debjit Bhowmik, B.

Study of Disintegrant Property of Moringa Oleifera Gum and its Comparison with other Superdisintegrants

Formulation and Evaluation of Oral disintegrated tablets of Alfuzosin Hydrochloride using superdisintegrants

Formulation and evaluation of oro-dispersible tablets of lafutidine

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

Available online through ISSN

International Journal of Pharma and Bio Sciences NOVEL CO-PROCESSED SUPERDISINTEGRANTS IN THE DESIGN OF FAST DISSOLVING TABLETS

INTERNATIONAL JOURNAL OF PHARMACY & LIFE SCIENCES

Formulation and Evaluation of Glicazide Mouth Dissolving Tablets

STABILITY STUDIES OF FORMULATED CONTROLLED RELEASE ACECLOFENAC TABLETS

Formulation, Optimization and Evaluation of Mouth Dissolving Tablet of Zidovudine

Formulation and Evaluation of Etoricoxib Oro Dispersable Tablets by Direct Compression Method

PHARMA SCIENCE MONITOR AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES

DESIGN, DEVELOPMENT AND OPTIMIZATION OF FAST DISSOLVING TABLET OF NEBIVOLOL HCL

FORMULATIO A D EVALUATIO OF ORO DISPERSIBLE TABLETS OF CLO AZEPAM BY DIRECT COMPRESSIO METHOD

International Journal of Pharmacy

FORMULATION AND EVALUATION OF CEFIXIME TRIHYDRATE ORAL DISINTEGRATING AGENTS

FABRICATION AND EVALUATION OF GLIMEPIRIDE CORDIA DICHOTOMA G.FORST FRUIT MUCILAGE SUSTAINED RELEASE MATRIX TABLETS

FORMULATION AND EVALUATION OF BISOPROLOL FUMARATE FAST DISSOLVING TABLET BY DIRECT COMPRESSION TECHNIQUES

Global College of Pharmacy, Kahnpur Khui, Tehsil Anandpur Sahib, Distt.- Ropar, Punjab, India

Optimization of valsartan tablet formulation by 2 3 factorial design

Pavan K et al IJARPB: 2013, 3(2), ISSN: Available online on Research Article

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Formulation and evaluation of oral dispersible tablets of aripiprazole

Int. Res J Pharm. App Sci., 2014; 4(1):47-51 ISSN:

Design and In-vitro Evaluation of Silymarin Bilayer Tablets

372 J App Pharm Vol. 6; Issue 4: ; October, 2014 Moazzem et al, 2014

Pharmacologyonline 2: (2011) ewsletter Mehul et al. FORMULATIO A D EVALUATIO OF ORODISPERSIBLE TABLETS OF PHE IRAMI E MALEATE

Formulation Development and Evaluation of Atorvastatin Calcium Tablets using Co-Processed Excipients

Formulation and Evaluation of Gastroretentive Dosage form of Ciprofloxacin Hydrochloride.

FORMULATION AND EVALUATION OF BILAYERED TABLET OF METFORMIN HYDROCHLORIDE AND PIOGLITAZONE HYDROCHLORIDE

Available online Research Article

Formulation and development of orodispersible tablet of Memantine HCl by sublimation approach

Journal of Chemical and Pharmaceutical Research

FORMULATION DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF BILAYER TABLETS OF AMOXICILLIN AND FAMOTIDINE

Adimoolam Senthil et al. IRJP 2 (1)

Scholars Research Library. Formulation and evaluation of rizatriptan benzoate orodispersible tablets

DESIGNING OF ORODISPERSIBLE TABLET OF DIETHYL CARBAMAZINE CITRATE FOR THE TREATMENT OF FILARIASIS

OPTIMIZATION OF CONTROLLED RELEASE GASTRORETENTIVE BUOYANT TABLET WITH XANTHAN GUM AND POLYOX WSR 1105

FORMULATION AND EVALUATION OF FAST DISSOLVING TABLETS OF VALSARTAN

Volume: I: Issue-2: Aug-Oct ISSN NOVEL APPROACH IN FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF ONDANSETRON HYDROCHLORIDE

Formulation and Evaluation of Rosuvastatin Immediate Release Tablets 10 Mg

Optimization of Atenolol Core Tablet CHAPTER 5: OPTIMIZATION OF FORMULATION OF ATENOLOL CORE TABLETS

Received on: Accepted on:

Formulation and Evaluation of Fast Dissolving Tablets of Ranitidine Hydrochloride Bookya Padmaja 1 *, Raparla Ramakrishna 1, Goutham Goud 2

DESIGN AND EVALUATION OF COST EFFECTIVE ORODISPERSIBLE TABLETS OF DIETHYLCARBAMAZINE CITRATE BY EFFERVESCENT METHOD

FORMULATION AND EVALUATION OF ACECLOFENAC SODIUM BILAYER SUSTAINED RELEASE TABLETS

Ajmer , India. * Correspondence rediffmail.com, Ph :

Development and characterization of orodispersible tablets of famotidine containing a subliming agent

Design and Characterization of Valsartan Loaded Press Coated Pulsatile Tablets

FORMULATION AND EVALUATION OF SUBLINGUAL TABLET FOR NARATRIPTA

COMPARATIVE EFFECT OF DIFFERENT HIGH FUNCTIONALITY EXCIPIENTS ON VARIOUS CHARACTERISTICS OF VARDENAFIL HCL TABLETS (BCS II DRUG)

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Adimoolam S et al. IRJP 1 (1)

DEVELOPMENT OF NON SODIUM EFFERVESCENT TABLET OF PARACETAMOL USING ARGININE CARBONATE

Formulation and evaluation of intraorally fast dissolving tablet of olmesartan medoxomil

Formulation and Evaluation of Mouth Dissolving Sublingual Tablets of Cimetidine to Treat Abdominal Cramps

FORMULATION AND EVALUATION OF MELT-IN-MOUTH TABLETS OF DOMPERIDONE CONTAINING MULTICOMPONENT INCLUSION COMPLEX

International Journal of Pharma and Bio Sciences V1(1)2010 FORMULATION AND EVALUATION OF ROSIGLITAZONE MOUTH DISSOLVING TABLET

Formulation Development, Evaluation and Comparative Study of Effects of Super Disintegrants in Cefixime Oral Disintegrating Tablets

International Journal of Pharmacology and Pharmaceutical Sciences 2016; Vol: 3, Issue: 3, 14-18

JOURNAL OF SCIENTIFIC & INNOVATIVE RESEARCH

Design and evaluation of immediate release tablets of divalproex sodium

DESIGN AND EVALUATION OF CONTROLLED RELEASE MATRIX TABLETS OF FLURBIPROFEN

FORMULATION & EVALUATION OF ORALLY DISINTEGRATING TABLET OF IBUPROFEN FOR PAEDIATRIC USE

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Studies on Carica Papaya Starch as a Pharmaceutical Excipient

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

Formulation And Evaluation Of Flurbiprofen Matrix Tablets For Colon Targeting

Formulation and evaluation of mouth dissolving tablets containing losartan potassium

FORMULATION AND EVALUATION OF FLOATING TABLETS OF NORFLOXACIN

Formulation and In-Vitro Evaluation of Leflunomide Tablet with Enhanced Dissolution

Development and Evaluation of Orally Disintegrating Tablet by Direct Compression Method

Research Article Formulation and Evaluation of Dual Component Tablets of Metoprolol tartrate

ISSN: CODEN Code: PIHNBQ ZDB-Number: IC Journal No: Vol. 2 No Online Available at

Volume: 2: Issue-3: July-Sept ISSN FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NICORANDIL

Asian Journal of Research in Pharmaceutical Sciences and Biotechnology

Transcription:

Formulation and Optimization of Lamotrigin Fast Dissolving Tablet Sachin S. Gupta 1, Hitesh Patel 2, B.G.Prajapati 2, Shreeraj Shah 1 1. L.J.Institute of Pharmacy.Sanand Cross road, Sarkhej-Gandhinagar Highway, Ahmedabad. 2. Shree S K Patel College of Pharmaceuticalducation &Research, Kherva Ganpat University. ABSTRACT: The objective of the present research was to prepare fast disintegrating tablet of lamotrigin because of its application in epilepsy and convulsion related problem. Fast on set of action and avoidance of abundant of water in oral route. Which is highly desirable in this type of disease condition. The effect of formulation and process variables such as hardness, disintegration time, and in vitro dissolution and physical characteristics of fast dissolving tablet were examined on optimized drug/super disintegrant ratio by 3 2 factorial designs. During the work tablets were prepared by direct compression using Kyron T-314 and sodium starch Glycolate as super disintegrant,where MCC,Lactose monohydrate for direct compression, aspartame as sweetner.the different powder blends were evaluated for pre-formulation parameters such as bulk density, tapped density, angle of repose,carr s index,hausner s ratio. The tablets were evaluated for post-compression parameters such as weight variation, Tablet hardness and tablet friability. In vitro Disintegration test, tablet thickness, in vitro dissolution profile. All the physical characteristics of powder blend and fibrillated tablet were within acceptable limits. The result of Dissolution studies indicated that formulation F7 release 98.70% of drug at 25 min interval which give the most successful of study.f7 batch contain Lamotrigin(Drug),SSG(4%),kyron T-314(2%) and other excipients.f7 batch was the optimized batch since it showed of Disintegration time(17sec),friability(0.91%) and %Drug release (98.70%). Key Words: Lamotrigin, Kyron T-314, Direct Compression, Sodium Starch Glycolate Article history: Received 08 Feb 2012 Accepted 23 March 2012 Available online 13 April 2012 For Correspondence: Mr. Sachin S.Gupta L.J.Institute of Pharmacy.Sanand Cross road, Sarkhej- Gandhinagar Highway, Ahmedabad. Gujarat. Email: sachin.gupta1228@gmail.com (www.jpsbr.org) INTRODUCTION 1-5 The concept of Fast Dissolving Drug Delivery System emerged from the desire to provide patient with conventional mean of taking their medication. Difficulty in swallowing (Dysphasia) is a common problem of all age groups, especially elderly and pediatrics, because of physiological changes associated with these groups of patients. Recently fast dissolving formulation is popular as Novel Drug Delivery Systems because they are easy to administer and lead to Patient Compliance Solid dosage forms that can be disintegrated, dissolved, or suspended by saliva in the mouth resulting in easy swallowing can provide significant benefits to the pediatric and geriatric populations. FDT are prepared by various techniques, mainly direct compression,lyophilization & moulding.but most simplicity & cost effectiveness of the direct compression techniques. Usually superdisintegrants are added to dry formulation to facilitate the break up or disintegration of tablet into smaller particle than can dissolve more rapidly. Lamotrigine *6 (2, 3 dichlorophenyl) 1, 2, 4 triazine 3, 5 diamine+ is an antiepileptic agent shown to be effective in adjunctive treatment for refractory Gupta S. S. et al 68

Partial seizures and generalized seizures. It works by inhibiting voltage dependent sodium channels, resulting in decreased release of the excitatory neurotransmitters glutamate and aspartate2. It has an elimination half life longer than 24 hr so once or twice daily dosing is possible in all patients. Lamotrigine is rapidly and completely absorbed after oral administration with negligible first-pass metabolism (absolute bioavailability is 98%). The bioavailability is not affected by food. Peak plasma concentrations occur anywhere from 1.4 to 4.8 h following drug administration (British National Formulary, 2009).Lamotrigine has a bitter taste. It is very slightly soluble in water (0.17 mg/ml at 25 C). The object of this study was to formulate lamotrigine ODT using direct compression technique and to clarify the effect of different superdisintegrants like Kyron T 314, Sodium starch glycolate (SSG), on the disintegrating and dissolution properties of tablets. MATERIALS AND METHODS Lamotrigine was received as gift samples by Concern Pharma Ltd., Ahmedabad. Kyron T 314 was obtained as a gift sample from Corel Pharma Ltd., Ahmedabad. Microcrystalline Cellulose was obtained as a gift sample from Maple Biotech Pvt.Ltd, Pune.Sodium starch glycolate was obtained as a gift sample from DMV-Fonterra Excipients, Germany.Lactose Monohydrate IP- was obtained as a gift sample from Signet Chemical Corporation Pvt.Ltd. Mumbai. Sodium Steryl Fumarate & Aersoil were obtained as a gift sample from S.D Fine Chem. Ltd.Mumbai.. All other chemicals/solvents used were of analytical grade. METHODS Preparation of Fast Dissolving tablets of Lamotrigine 6 The critical parameters to formulate a fast dissolving tablet are choice of super disintegrant and optimization of concentration of super disintegrant. The Main criteria for fast dissolving tablet is to dissolving tablet or disintegrate Rapidly in oral cavity in 15-60 seconds without need of water and should have pleasant mouth feel. The super disintegrant (Kyron T-314 & SSG) were used to formulate the tablets. All the ingredient as shown in table 1.were Co-ground in a pestle & motor then Aerosil & SSF were added &mixed for 10 min.the mixed blend of drug-excipient was compressed using single punch rotary tablet machine. Full Factorial Design A 3 2 randomized full factorial design was adopted to optimize the variables. In this design 2 factors were evaluated, each at 3 levels, and experimental trials were performed at all 9 possible combinations. The amounts of super Disintigrant agent Kyron T-314 (X 1 ) and the amount of SSG (X 2 ), were selected as independent variables. The disintegration time (DT) and percent friability (%F) were selected as dependent variables. Batches of factorial design are shown in Table 2. EVALUATION OF OF LAMOTRIGINE FAST DISSOLVING TABLETS Hardness 7 The prepared tablets hardness was measured by using Monsanto hardness tester. The hardness was measured in terms of kg/cm 2. Thickness and diameter 7 Thickness and diameter of prepared tablets were tested by vernier callipers and the average was calculated. Weight variation 7 Twenty tablets were selected at random and weighed individually. The individual weights were compared with the average weight for determination of weight variation. The percentage deviation was calculated and then compared with USP specifications. Friability 7 Friability of tablets was measured by using Roche Friabilator (Electrolab, Mumbai, India). Friability was evaluated from the percentage weight loss of 20 tablets tumbled in a friabilator at 25 rpm for 4 min. The tablets were dedusted, and the loss in weight caused by fracture or abrasion was recorded as the percentage weight loss. Friability below 1% was considered acceptable. % Friability = [(Initial weight Final weight) / initial weight] * 100 Drug content 4 Twenty tablets were powdered; powder equivalent to 50 mg of lamotrigine was accurately weighed and transferred into a 100 ml volumetric flask. Then, the volume was made up to 100 ml with 0.1N HCl. The filtrate was collected and diluted with sufficient amount of 0.1N HCl till the concentration of the drug lies within the standard plot range. The diluted solution was analyzed for the lamotrigine content by UV spectrophotometer (UV 1700 Shimadzu Corporation, Japan) using 0.1N HCl as a blank at 254 nm. Gupta S. S. et al 69

Table 1. Composition of Lamotrigine FDT. Batches F1 F2 F3 F4 F5 F6 F7 F8 F9 Lamotrigine 5 5 5 5 5 5 5 5 5 Lactose 95.1 96.5 97.9 96.5 97.9 99.3 97.9 99.3 100.7 MCC 24.5 24.5 24.5 24.5 24.5 24.5 24.5 24.5 24.5 KyronT-314 5.6 5.6 5.6 4.2 4.2 4.2 2.8 2.8 2.8 SSG 5.6 4.2 2.8 5.6 4.2 2.8 5.6 4.2 2.8 Aspartame 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 Aerosil 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 SSF 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 1.4 Total 140 140 140 140 140 140 140 140 140 TABLE 2. Factorial Design Batches of Fast Dissolving Tablet Batch code X 1 X 2 F 1-1 -1 F 2-1 0 F 3-1 1 F 4 0-1 F 5 0 0 F 6 0 1 F 7 1-1 F 8 1 0 F 9 1 1 X 1 =Amount of Kyron T-314 X 2 =Amount of Sodium Starch Glycolates In-vitro disintegration time 8 Disintegration time was determined using USP tablet disintegration apparatus (ED2L Electrolab, India) using 900 ml distilled water without disk at 37 C±2 C temperature. A tablet was placed in each of the six tubes of the apparatus. The time taken for complete disintegration of the tablet with no palatable mass remaining in the apparatus was measured in seconds In Vitro Dissolution studies 8 The dissolution study was performed for all batches and marketed conventional tablet formulation by usingapparatus no. 2 or paddle apparatus (Electrolab, TDT 08L) (Indian Pharmacopoeia, 2007). The dissolution medium was 0.1 N HCl (ph 1.2, 900 ml, 37.0 ± 0.5 C). The rate of agitation of the paddle was 50 rpm. Aliquots of 10 ml were withdrawn at specific time interval at 1,3,5,10,15,20,30 min, filtered and absorbance was measured at 254 nm using Shimadzu by UV- 1601 double spectrophotometer. TABLE 3. Observation Table: Batch No. Hardness (Kg/cm 3 ) Disintegration Time (Sec) Friability (%w/w) F 1 3.9 20 0.84 F 2 4.2 17.9 0.87 F 3 3.8 18.3 0.89 F 4 3.9 22.5 0.89 F 5 3.5 18.9 0.94 F 6 3.5 18.1 0.95 F 7 3.4 17 0.84 F 8 3.6 17.5 0.96 F 9 3.2 17 1.21 RESULTS AND DISCUSSION Nine formulations of Lamotrigine were prepared with varying concentration of two superdisintegrants: Sodium starch glycolate & Kyron T-314 and microcrystalline cellulose, and Lactose Mono hydrate IP were used as diluents (Table 1). For each formulation, blend of drug and excipients were prepared and evaluated for various parameters as explained earlier. The powder blend was compressed using direct compression technique. Bulk density, was found in the range of 0.360-0.528 g/cm3 and the tapped density between 0.470-0.623 g/cm3. Using these two density data hausner s ratio and compressibility index was calculated. The powder blends of all formulations had hausner s ratio less than 1.25 indicates better flow property. The compressibility index was found between 13.5-19.7 which indicates a fairly good flowbility of the powder blend. The good flowability of the powder blend was also angle of repose (range of 24-34) which is below 40 indicating good flowability. Tablets were prepared using direct Gupta S. S. et al 70

TABLE 4.In Vitro Dissolution Data Table Time(Min) F1 F2 F3 F4 F5 F6 F7 F8 F9 0 0 0 0 0 0 0 0 0 0 5 21.10 21.40 20.20 22.30 21.40 23.40 24.90 19.10 17.20 10 36.00 33.00 38.10 38.01 36.12 34.90 39.11 29.90 30.13 15 62.35 61.44 63.10 63.01 60.75 62.11 68.91 58.64 57.01 20 82.31 80.11 81.34 83.04 79.77 80.11 86.11 71.33 70.29 25 90.00 9420 89.750 91.11 90.22 91.18 98.70 86.28 82.16 compression technique. Since the powder material was free flowing, tablets were obtained of uniform weight due of uniform die fill, with acceptable weight variations as per I.P. The hardness of tablet range b/w 3.25-4.3(Kg/cm 3) was good mechanical resistance of the tablets shows in Table 3. The invitro disintegration time (DT) of the tablets was found to less than 30 sec which fulfilling the official requirements (< 3 min) for fast dissolving tablets (European Pharmacopoeia, 2001) & Friability also lass then 1% which fulfilling the official requirements for tablet as per I.P.(Table 3). The cumulative percentage drug release of the tablets from the prepared batches tablet formulation is shown in Table 4. It was observed that nearly all the batches showed drug release close to 100% in 0.1 N HCl. In 0.1 N HCl, batch F 7 gave better release profile of around 99% in 25 min as compared to other batches. CONCLUSION: The use of superdisintegrants for preparation of fast dissolving tablets is highly effective and commercially feasible. These superdisintegrants accelerate disintegration/dissolution of tablets by virtue of their ability to absorb a large amount of water when exposed to an aqueous environment. Kyron T-314 & Sodium Starch Glycolate used as a superdisintegrants agent increases the porosity of the tablets due to which the absorption of water takes place at high rate that results in breaking of tablets and therefore faster disintegration/dissolution From this research work, it can be concluded that among all the prepared batched from F1 to F9, batch F7 shows optimum characteristic with highest drug release and lowest disintegration time. So the batch prepared by the combination of two disintegrating agent Kyron T-314 (2%) and SSG (4%) was optimized batch. REFERENCES 1. Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. Third Edition, Varghese Publication House, Bombay, India 1987: 296 300. 2. The Science and Practice of pharmacy, Remingtion part-i, 20th Edition-2000, Published by philladelphia college of pharmacy & Science. 3..Prakash Goudanavar et al,. Development and characterization of lamotrigine orodispersible tablets Inclusion complex with hydroxypropyl β cyclodextrin International Journal of Pharmacy and Pharmaceutical Sciences 2011;3(3):208-214 4 P.S. Zade, P.S. Kawtikwar, D.M. Sakarkar Formulation, Evaluation and Optimization of Fast dissolving tablet containing Tizanidine Hydrochloride International Journal of PharmTech Research,2009 1 (1):34-42 5.. Vineet Bhardwaj, Mayank Bansal and P.K. Sharma Formulation and Evaluation of Fast Dissolving Tablets of Amlodipine Besylate Using Different Super Disintegrants and Camphor as Sublimating Agent American-Eurasian Journal of Scientific Research 2010 5 (4): 264-269 6.C. Patil1 et al., Effect of various superdisintegrants on the drug release profile and disintegration time of Lamotrigine orally disintegrating tablets African Journal of Pharmacy and Pharmacology January 2011 5(1): 76-82, 7. Swamy PV,et al.,. Or dispersible tablets of meloxicam using disintegrant blends for improved efficacy. Indian J Pharm Sci 2007; 69(6): 836 840. 8.Pankaj P. Amrutkar, Sanjay B. Patil, Abhijeet N. Todarwal, Design and evaluation of taste masked chewable dispersible tablets lamotrigine by melt granulation International Journal of Drug Delivery 2010 2 183-191 Gupta S. S. et al 71

9.. Jain CP, Naruka PS. Formulation and evaluation of fast dissolving tablets of valsartan. Int J Pharm Pharm Sci 2009; 1(1): 219 226 10 Hand book of Pharmaceutical Excipients Fifth edition.edited By Raymond Rowe,PaulJ.Sheskey & sian c.owen. 11. http://www.drugbank.ca/drugs/db00555 Gupta S. S. et al 72